Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 14555560.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
STUDY OBJECTIVE: We conducted the first randomized controlled study to assess the effects of short-term 28% and 100% oxygen on PaCO(2) and peak expiratory flow rate (PEFR) in patients with acute severe asthma. PATIENTS AND INTERVENTIONS: Seventy-four patients (mean age, 37.9 +/- 9.7 years [+/- SD]; PEFR, 41.0 +/- 12.1% of predicted) from two emergency departments were randomized to receive 28% or 100% oxygen during 20 min. RESULTS: The administration of 100% oxygen significantly increases PaCO(2) (p = 0.03) and decreases PEFR (p = 0.001) as compared with administration of 28% oxygen. PaCO(2) before and during oxygen administration correlated significantly (p = 0.001) in both groups. Patients breathing 28% oxygen experienced a PaCO(2) fall; on the contrary, patients who received 100% oxygen showed an increase in PaCO(2), particularly those with PaCO(2) before oxygen treatment > 40 mm Hg. CONCLUSIONS: This study confirmed previous observations that oxygen dose should be variable and based on achieving and maintaining target arterial oxygen saturation measured by pulse oximetry > or = 92% rather than on prescribing predetermined concentrations or flow rates of inspired oxygen.
Medical subject headings
- Asthma
- Oxygen